![Mark Lowdell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lowdell
Founder at
INMUNE BIO INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Mark Lowdell is the founder of Achilles Therapeutics UK Ltd. founded in 2016.
Dr. Lowdell is the founder of Achilles Therapeutics Plc founded in 2020.
Dr. Lowdell is the founder of Autolomous Ltd. founded in 2019 and holds the title of Director since 2021.
Dr. Lowdell is the founder of INmune Bio, Inc. founded in 2015 and holds the title of Chief Scientific & Manufacturing Officer since 2018.
Dr. Lowdell is also the founder of Kuur Therapeutics Ltd.,Immune Ventures Ltd...
Dr. Lowdell holds the position of Director-Cellular Therapy at Royal Free London NHS Foundation Trust since 2009.
Dr. Lowdell is Director-Centre for Cell, Gene & Tissue at Royal Free Hospital Medical School.
Dr. Lowdell is a Professor at University College London since 1994.
Dr. Lowdell is Vice President at International Society For Cell & Gene Therapy.
Dr. Lowdell earned doctorates in 1992 from St Bartholomew's Hospital Medical College and Blizard Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INMUNE BIO, INC. 5.68% | 2026-04-19 | 1,510,806 ( 5.68% ) | 2 M $ | 2026-05-30 |
Mark Lowdell active positions
| Companies | Position | Start |
|---|---|---|
| INMUNE BIO INC. | Founder | 2015-09-24 |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1993-12-31 |
Royal Free London NHS Foundation Trust
 Royal Free London NHS Foundation Trust Miscellaneous Commercial ServicesCommercial Services Operates as an NHS foundation trust which provides hospitals and clinics services | Corporate Officer/Principal | 2009-01-31 |
Royal Free Hospital Medical School
 Royal Free Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
International Society For Cell & Gene Therapy | Corporate Officer/Principal | - |
Autolomous Ltd.
 Autolomous Ltd. Packaged SoftwareTechnology Services Develops a technology platform for cell and gene therapy manufacturers | Founder | 2019-01-31 |
Former positions of Mark Lowdell
| Companies | Position | End |
|---|---|---|
Immune Ventures Ltd. | Founder | - |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Founder | - |
| ACHILLES THERAPEUTICS PLC | Founder | - |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Mark Lowdell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops cell immunotherapies for treatment of solid and hematological malignancies | Health Technology |
Royal Free London NHS Foundation Trust
Royal Free London NHS Foundation Trust Miscellaneous Commercial ServicesCommercial Services Operates as an NHS foundation trust which provides hospitals and clinics services | Commercial Services |
St Bartholomew's Hospital Medical College
 St Bartholomew's Hospital Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
INmune Bio, Inc.
 INmune Bio, Inc. BiotechnologyHealth Technology Develops therapies that harness the patient's immune system to treat cancer | Health Technology |
Royal Free Hospital Medical School
Royal Free Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blizard Institute
 Blizard Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
Immune Ventures Ltd. | |
International Society For Cell & Gene Therapy | |
Autolomous Ltd.
Autolomous Ltd. Packaged SoftwareTechnology Services Develops a technology platform for cell and gene therapy manufacturers | Technology Services |
- Stock Market
- Insiders
- Mark Lowdell
